Training in drug abuse research: behavior and neurobiology

药物滥用研究培训:行为和神经生物学

基本信息

项目摘要

 DESCRIPTION (provided by applicant): This application in response to PA-11-184 is the first competing continuation of a new program entitled "Training in drug abuse research: behavior and neurobiology" that provides research training and career development activities for postdoctoral fellows who aspire to careers in the area of drug addiction. In its first 4 years the Program has grown from 2 to 5 training positions, plus 1 additional position supported by UTHSCSA for a total of 6. All of the available positions have been filled with highly qualified and successful young investigators who have conducted addiction research full time while supported by the Program. Trainees who completed the Program continue their careers in biomedical science and two current trainees recently accepted tenure-track assistant professor positions at major universities where they will conduct addiction research. To date, 78% of trainees have been women and 33% of trainees have been underrepresented minorities. The 22 faculty mentors, including 6 junior mentors that are assisted by senior mentors, are well funded by the NIH and other agencies to conduct addiction research, and their expertise spans molecular biology to neurochemistry, behavior, and human clinical trials. In addition to providing one training position for the Program (for the past 2 years and committed for the next 5 years), UTHSCSA provides protected time for the Program Director, administrative support, including 10% of the Program Coordinator, as well as financial support for a wide variety of training and educational activities that are part of, or complementary to, the Program, including a new Office of Postdoctoral Affairs. The Program is administered by an experienced Program Director with assistance from a Program Coordinator as well as Internal and External Advisory Committees. This application requests 5 additional years of support (6 positions) for this new and highly successful postdoctoral training program that strives to provide rigorous interdisciplinary trainin in behavioral and neurobiological addiction research, thereby addressing an increasing demand for addiction scientists who can succeed in the current translational research environment.
 描述(由申请人提供):本申请响应PA-11-184是一个新的程序题为“药物滥用研究培训:行为和神经生物学”,提供研究培训和职业发展活动的博士后研究员谁渴望在吸毒成瘾领域的职业生涯的第一个竞争延续。在最初的4年里,该计划从2个培训职位增加到5个,加上UTHSCSA支持的1个额外职位,总共有6个。所有可用的职位都由高素质和 成功的年轻研究人员,他们在该计划的支持下全职进行成瘾研究。完成该计划的学员继续他们在生物医学科学的职业生涯,两名目前的学员最近接受了主要大学的终身助理教授职位,他们将在那里进行成瘾研究。迄今为止,78%的受训者是妇女,33%的受训者是代表性不足的少数民族。22名教师导师,包括6名由高级导师协助的初级导师,由NIH和其他机构提供充足的资金进行成瘾研究,他们的专业知识涵盖分子生物学,神经化学,行为和人体临床试验。除了为该方案提供一个培训职位外,(过去2年和未来5年的承诺),UTHSCSA为项目总监提供受保护的时间,行政支持,包括10%的项目协调员,以及为作为项目一部分或补充的各种培训和教育活动提供财政支持,包括一个新的博士后事务办公室该计划由一位经验丰富的计划主任在计划协调员以及内部和外部咨询委员会的协助下管理。该申请要求为这个新的非常成功的博士后培训计划提供额外5年的支持(6个职位),该计划致力于在行为和神经生物学成瘾研究方面提供严格的跨学科培训,从而解决对成瘾科学家日益增长的需求,他们可以在当前的转化研究环境中取得成功。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHARLES P FRANCE其他文献

CHARLES P FRANCE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHARLES P FRANCE', 18)}}的其他基金

Methocinnamox (MCAM): A novel opioid receptor antagonist
Methocinnamox (MCAM):一种新型阿片受体拮抗剂
  • 批准号:
    10844948
  • 财政年份:
    2023
  • 资助金额:
    $ 42.07万
  • 项目类别:
A novel opioid receptor antagonist for treating abuse and overdose
一种用于治疗滥用和过量的新型阿片受体拮抗剂
  • 批准号:
    10353379
  • 财政年份:
    2019
  • 资助金额:
    $ 42.07万
  • 项目类别:
A novel opioid receptor antagonist for treating abuse and overdose
一种用于治疗滥用和过量的新型阿片受体拮抗剂
  • 批准号:
    9892987
  • 财政年份:
    2019
  • 资助金额:
    $ 42.07万
  • 项目类别:
Methocinnamox (MCAM): A novel õ-opioid receptor antagonist for opioid use disorders
Methocinnamox (MCAM):一种新型 α-阿片受体拮抗剂,用于治疗阿片类药物使用障碍
  • 批准号:
    10477526
  • 财政年份:
    2019
  • 资助金额:
    $ 42.07万
  • 项目类别:
Methocinnamox (MCAM): A novel õ-opioid receptor antagonist for opioid use disorders
Methocinnamox (MCAM):一种新型 α-阿片受体拮抗剂,用于治疗阿片类药物使用障碍
  • 批准号:
    10763458
  • 财政年份:
    2019
  • 资助金额:
    $ 42.07万
  • 项目类别:
A novel opioid receptor antagonist for treating abuse and overdose
一种用于治疗滥用和过量的新型阿片受体拮抗剂
  • 批准号:
    10092999
  • 财政年份:
    2019
  • 资助金额:
    $ 42.07万
  • 项目类别:
A novel opioid receptor antagonist for treating abuse and overdose
一种用于治疗滥用和过量的新型阿片受体拮抗剂
  • 批准号:
    10561706
  • 财政年份:
    2019
  • 资助金额:
    $ 42.07万
  • 项目类别:
Evaluation of the 5-HT2C agonist lorcaserin as potential treatment for cocaine ab
5-HT2C 激动剂氯卡色林作为可卡因抗体潜在治疗方法的评估
  • 批准号:
    9008117
  • 财政年份:
    2013
  • 资助金额:
    $ 42.07万
  • 项目类别:
Evaluation of the 5-HT2C agonist lorcaserin as potential treatment for cocaine ab
5-HT2C 激动剂氯卡色林作为可卡因抗体潜在治疗方法的评估
  • 批准号:
    8714994
  • 财政年份:
    2013
  • 资助金额:
    $ 42.07万
  • 项目类别:
Evaluation of the 5-HT2C agonist lorcaserin as potential treatment for cocaine ab
5-HT2C 激动剂氯卡色林作为可卡因抗体潜在治疗方法的评估
  • 批准号:
    8652970
  • 财政年份:
    2013
  • 资助金额:
    $ 42.07万
  • 项目类别:

相似海外基金

The Neurobiology of Drug Abuse
药物滥用的神经生物学
  • 批准号:
    10555567
  • 财政年份:
    2017
  • 资助金额:
    $ 42.07万
  • 项目类别:
Training in Drug Abuse Research: Behavior and Neurobiology
药物滥用研究培训:行为和神经生物学
  • 批准号:
    8266367
  • 财政年份:
    2011
  • 资助金额:
    $ 42.07万
  • 项目类别:
Training in Drug Abuse Research: Behavior and Neurobiology
药物滥用研究培训:行为和神经生物学
  • 批准号:
    8678888
  • 财政年份:
    2011
  • 资助金额:
    $ 42.07万
  • 项目类别:
Postdoctoral Training in Drug Abuse Research: Behavior & Neurobiology
药物滥用研究博士后培训:行为
  • 批准号:
    10200482
  • 财政年份:
    2011
  • 资助金额:
    $ 42.07万
  • 项目类别:
TRAINING PROGRAM IN THE NEUROBIOLOGY OF DRUG ABUSE
药物滥用神经生物学培训计划
  • 批准号:
    8357409
  • 财政年份:
    2011
  • 资助金额:
    $ 42.07万
  • 项目类别:
Training in Drug Abuse Research: Behavior and Neurobiology
药物滥用研究培训:行为和神经生物学
  • 批准号:
    8484806
  • 财政年份:
    2011
  • 资助金额:
    $ 42.07万
  • 项目类别:
Training in Drug Abuse Research: Behavior and Neurobiology
药物滥用研究培训:行为和神经生物学
  • 批准号:
    8077836
  • 财政年份:
    2011
  • 资助金额:
    $ 42.07万
  • 项目类别:
Postdoctoral Training in Drug Abuse Research: Behavior & Neurobiology
药物滥用研究博士后培训:行为
  • 批准号:
    10403619
  • 财政年份:
    2011
  • 资助金额:
    $ 42.07万
  • 项目类别:
Postdoctoral Training in Drug Abuse Research: Behavior & Neurobiology
药物滥用研究博士后培训:行为
  • 批准号:
    10626044
  • 财政年份:
    2011
  • 资助金额:
    $ 42.07万
  • 项目类别:
TRAINING PROGRAM IN THE NEUROBIOLOGY OF DRUG ABUSE
药物滥用神经生物学培训计划
  • 批准号:
    8172339
  • 财政年份:
    2010
  • 资助金额:
    $ 42.07万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了